Skip to Content

Calamos International Growth C CIGCX

Medalist Rating as of | See Calamos Investment Hub
  • NAV / 1-Day Return 17.70  /  0.00
  • Total Assets 243.5 Mil
  • Adj. Expense Ratio
    1.950%
  • Expense Ratio 1.950%
  • Distribution Fee Level Above Average
  • Share Class Type Level Load
  • Category Foreign Large Growth
  • Investment Style Large Growth
  • Min. Initial Investment 2,500
  • Status Open
  • TTM Yield
  • Turnover 131%

USD | NAV as of Mar 27, 2024 | 1-Day Return as of Mar 27, 2024, 10:07 PM GMT+0

Morningstar’s Analysis CIGCX

Will CIGCX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Calamos International Growth C boasts strong Process and People Pillar ratings, but other weaknesses hold this strategy's Morningstar Medalist Rating at Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the highest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings CIGCX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 33.7
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novo Nordisk A/S Class B

6.23 14.1 Mil
Healthcare

ASML Holding NV

3.87 8.7 Mil
Technology

Advantest Corp

3.70 8.4 Mil
Technology

Rolls-Royce Holdings PLC

3.48 7.8 Mil
Industrials

Shopify Inc Registered Shs -A- Subord Vtg

3.07 6.9 Mil
Technology

Taiwan Semiconductor Manufacturing Co Ltd

2.89 6.5 Mil
Technology

Constellation Software Inc

2.73 6.1 Mil
Technology

Gerresheimer AG

2.61 5.9 Mil
Healthcare

MercadoLibre Inc

2.59 5.8 Mil
Consumer Cyclical

SAP SE

2.58 5.8 Mil
Technology